7.12

6.16% 0.4132

Forte Biosciences Inc (FBRX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$6.7068

Offen:

$7.33

24-Stunden-Volumen:

18,708

Relative Volume:

0.54

Marktkapitalisierung:

$46.14M

Einnahmen:

Nettoeinkommen (Verlust:

$-31.48M

KGV:

-6.8462

EPS:

-1.04

Netto-Cashflow:

$-28.71M

1W Leistung:

+1.57%

1M Leistung:

-13.17%

6M Leistung:

+54.11%

1J Leistung:

-60.24%

1-Tages-Spanne:

$6.6974

$7.4078

1-Wochen-Bereich:

$4.90

$7.4247

52-Wochen-Spanne:

$4.11

$28.68

Forte Biosciences Inc Stock (FBRX) Company Profile

Firmenname

Forte Biosciences Inc

Sektor

Healthcare (1153)

Branche

Biotechnology (673)

Telefon

(310) 618-6994

Adresse

3060 PEGASUS PARK DRIVE, DALLAS, CA

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-11

Neueste SEC-Einreichungen

FBRX's Discussions on Twitter

Vergleichen Sie FBRX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
FBRX Forte Biosciences Inc	7.12	46.14M	0	-31.48M	-28.71M	-1.04
VRTX Vertex Pharmaceuticals Inc	496.49	122.76B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	610.86	61.38B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	620.97	36.37B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	254.85	30.12B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	249.46	24.70B	3.81B	-644.79M	-669.77M	-6.24

Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-01-21	Eingeleitet	TD Cowen	Buy
2024-04-08	Hochstufung	Ladenburg Thalmann	Neutral → Buy
2021-09-20	Hochstufung	Chardan Capital Markets	Sell → Buy
2021-09-03	Herabstufung	B. Riley Securities	Buy → Neutral
2021-09-03	Herabstufung	Chardan Capital Markets	Buy → Sell
2021-09-03	Herabstufung	Ladenburg Thalmann	Buy → Neutral
2021-09-03	Herabstufung	Truist	Buy → Hold
2021-05-14	Eingeleitet	B. Riley Securities	Buy
2021-03-26	Eingeleitet	Citigroup	Buy
2020-08-28	Hochstufung	Chardan Capital Markets	Neutral → Buy
2020-08-25	Eingeleitet	Truist	Buy

Alle ansehen

Forte Biosciences Inc Aktie (FBRX) Neueste Nachrichten

Apr 18, 2025

Forte Biosciences sets Annual Meeting for May 29 By Investing.com - Investing.com Canada

Apr 18, 2025

Forte Biosciences sets Annual Meeting for May 29 - Investing.com Australia

Apr 18, 2025

Pre-market Movers: OPTN, WINT, AKBA, GCTK... - RTTNews

Apr 18, 2025

Traders Buy High Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - Defense World

Apr 18, 2025

Apr 17, 2025

Mr. Ethan Billings recommends paying close attention to biotech stocks - FinancialContent

Apr 17, 2025

Apr 07, 2025

Forte Biosciences Sees Unusually Large Options Volume (NASDAQ:FBRX) - Defense World

Apr 03, 2025

Chardan Capital Issues Pessimistic Forecast for Forte Biosciences (NASDAQ:FBRX) Stock Price - Defense World

Apr 03, 2025

Apr 02, 2025

Chardan Adjusts Price Target on Forte Biosciences to $61 From $64, Maintains Buy Rating - MarketScreener

Apr 02, 2025

Forte Biosciences Reports 2024 Progress and Financials - TipRanks

Apr 02, 2025

Apr 01, 2025

Is Forte Biosciences (NASDAQ:FBRX) In A Good Position To Deliver On Growth Plans? - Yahoo

Apr 01, 2025

Mar 31, 2025

Forte's Celiac Treatment Shows Promise: Zero Dropouts and $58.4M War Chest - Stock Titan

Mar 31, 2025

Forte Biosciences, Inc. Announces Results and Provides Clinical Update - Bluefield Daily Telegraph

Mar 31, 2025

Mar 28, 2025

Forte Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 28, 2025

Forte Biosciences Inc Files For Mixed Shelf Of Up To $300 MillionSEC Filing - MarketScreener

Mar 28, 2025

Forte Biosciences, Inc. SEC 10-K Report - TradingView

Mar 28, 2025